Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
March 2025 Monthly KPI Fiscal Year Ending October 2025
CellSource Transfers Patent Application for Animal Regenerative Medicine to Anicom Specialty Medical Institute
CellSource Begins Monthly Reporting of KPI Results in Contract Processing Services
Earnings Presentation Q1 FY10/2025
Notice Concerning Absorption-Type Company Split of a Subsidiary
[Summary]Consolidated Financial Results for the Three Months Ended January 31, 2025 (Under Japanese GAAP)
CellSource, Nov-Jan (1Q) Ordinary Profit Turns to Loss
Notice Regarding Change in Representative Director
Notice Regarding Distribution of Surplus (Dividend)
Notice Concerning Difference between Full-Year Financial Forecasts and Actual Results Related to Provision for Contract Losses
CellSource, 58% Increase in Ordinary Profit for The Current Fiscal Year
FY10/2024 Earnings Presentation and CellSource Vision
Non-consolidated Financial Results for the Fiscal Year Ended October 31, 2024 (Under Japanese GAAP)
Notice Regarding Publication of Consolidated Financial Result Forecasts in Connection with Commencement of Consolidated Accounting
NTT DOCOMO and CellSource Begin Collaboration Aimed at Expanding Awareness of Regenerative Medicine
CellSource, a Regenerative Medicine-Related Business and JAPAN POST sign Agreement for Collaboration in Medical Fitness
Announcement Regarding Increase in Incentive Rate for Employee Stock Ownership Plan
Notice Regarding Establishment of a Subsidiary
Notice Regarding Changes in Representative Directors and New Executive Structure
CellSource Supports Kobe City's Women's Empowerment Project Through a Corporate Version of the Hometown Tax Donation Program